IDEXX Laboratories Inc (IDXX) support and resistance · P/E 40, rev $2.36B
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
This page maps IDEXX Laboratories Inc (IDXX) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IDXX 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IDXX quote page for the session range and the stock page for the full model.
Not investment advice.